LIDOCAÏNE KABI 20 mg/ml, solution for injection 50 ampoules of 20 ml
Active ingredients: Lidocaine, Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection50 ampoules of 20 mlinfiltration;intramusculaire;intraveineuse;péridurale;périneurale;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LIDOCAÏNE KABI 20 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;intramusculaire;intraveineuse;péridurale;périneurale;sous-cutanée
- Presentation description
- 50 ampoules polyéthylène basse densité (PEBD) de 20 mL
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Mar 2019
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61164434CIP75505688CIP133400955056881Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIDOCAÏNEsolution | 16,22 mg · 1 mL de solution | FT |
| LIDOCAÏNE (CHLORHYDRATE DE) MONOHYDRATÉsolution | 20 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.